Dravet Syndrome

Also known as: Severe myoclonic epilepsy of infancy / Epilepsy, Myoclonic, Infantile, Severe

DrugDrug NameDrug Description
DB09118StiripentolAn anticonvulsant agent used with clobazam and valproate as an adjunct to treat refractory generalized tonic-clonic seizures in Dravet syndrome.
DrugDrug NamePhaseStatusCount
DB09061Cannabidiol1 / 2Terminated1
DB09061Cannabidiol2Completed1
DB00661Verapamil2Completed1
DB09061Cannabidiol3Active Not Recruiting1
DB09061Cannabidiol3Completed2
DB09061Cannabidiol3Withdrawn1
DB00349Clobazam3Terminated1
DB00349Clobazam3Withdrawn1
DB00574Fenfluramine3Active Not Recruiting1
DB00574Fenfluramine3Enrolling by Invitation3
DB09118Stiripentol4No Longer Available1
DB00574FenfluramineNot AvailableAvailable1
DB09118StiripentolNot AvailableApproved for Marketing1
DB09118StiripentolNot AvailableNo Longer Available2